Form 8-K - Current report:
SEC Accession No. 0001493152-25-008471
Filing Date
2025-02-27
Accepted
2025-02-27 09:29:42
Documents
21
Period of Report
2025-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 65522
2 ex4-1.htm EX-4.1 129656
3 ex4-2.htm EX-4.2 97008
4 ex10-1.htm EX-10.1 38572
5 ex99-1.htm EX-99.1 15580
6 ex10-1_001.jpg GRAPHIC 13458
7 ex99-1_001.jpg GRAPHIC 26857
  Complete submission text file 0001493152-25-008471.txt   696346

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE biaf-20250225.xsd EX-101.SCH 3787
9 XBRL DEFINITION FILE biaf-20250225_def.xml EX-101.DEF 26629
10 XBRL LABEL FILE biaf-20250225_lab.xml EX-101.LAB 36679
11 XBRL PRESENTATION FILE biaf-20250225_pre.xml EX-101.PRE 25253
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5821
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25673619
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)